Open AccessPharmacist‐led hypertension drug use review
Author(s) -
Braybrook S.,
Thomas J.,
Wilkin P. S.,
Haynes W.,
Jarvis I.,
Conaty D.
Publication year - 2002
Publication title -
international journal of pharmacy practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.42
H-Index - 37
eISSN - 2042-7174
pISSN - 0961-7671
DOI - 10.1111/j.2042-7174.2002.tb00621.x
Subject(s) - medicine , drug , pharmacist , family medicine , intensive care medicine , pharmacology , pharmacy
Focal points Few studies have shown the impact of pharmacists on the control of hypertension in patients Many studies have shown that there is scope for improvement in the control of hypertension A review of patients receiving nifedipine or amlodipine at two GP practices was carried out in line with British Hypertension Society guidelines Patients were also assessed with a view to changing calcium channel blocker to felodipine since trials have demonstrated equal benefit in terms of blood pressure control and long term outcomes of morbidity and mortality This review demonstrated that a pharmacist can actively review and improve the control of hypertension in a primary care population whilst optimising prescribing costs